Market Pathways Scorecard, November 2020

article image

Our monthly infographic of stats and facts for the medtech regulatory and policy community.

Medtech stats at a glance. This month: FDA COVID-19 EUAs far outnumber novel device approvals in 2020; the rollout of guidance documents to support MDR and IVDR is speeding up; and there’s an uptick in the number of new CPT codes coming out of AMA’s CPT Editorial Panel. 

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: